Global Biochips (Microarrays/Lab-on-Chip) Market 2015 - Forecast To 2021: Market is expected to grow at a CAGR of 18%
DUBLIN, May 13, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/4tk7vn/biochips) has announced the addition of the "Biochips (Microarrays/Lab-on-Chip) Global Market - Forecast To 2021" report to their offering.
The global biochips market is expected to grow at a CAGR of around 18.0 % from 2014 to 2019
Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.
The global biochips market is broadly classified as micro arrays and lab on chip/micro fluidic systems based on its type. Biochips market is segmented on the basis of application as diagnostic (In vitro diagnosis, cancer diagnosis, and point of care diagnosis), drug delivery systems (high throughput screening), research (genomics and proteomics) and others (defense, forensic). Based on the products the biochips market is further segmented into microarrays, reagents and consumables and others.
Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.
Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.
North America accounts for the highest market share followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favorable government policies makes U.S. the leader of Biochips market. However, Asian countries especially India and China's are the fast growing regions with its growing demand for biochips and increasing research investments.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
4 Biochips Architecture
5 Biochips Global Market, by Types
6 Biochips Global Market, by Products
7 Biochips Global Market, by Applications
8 Biochips Global Market, by End-Users
9 Regional Market Analysis
10 Company Developments
11 Major Player Profiles
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories
- Cepheid, Inc.
- Fluidigm Corporation.
- GE Healthcare
- Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Perkinelmer, Inc.
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/4tk7vn/biochips
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article